Lung Cancer Patient Story: Multidisciplinary Expertise Backed by Cutting-edge Treatment
After a diagnosis of non-small cell lung cancer, Flora McCoy-Greene sought the latest treatment from an integrated cancer care team at Mass General.
Departments, Centers, & Programs:
Treats:
Mass General Cancer Center: Thoracic Oncology
55 Fruit St.
Boston, MA 02114
Phone: 877-726-5130
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
After a diagnosis of non-small cell lung cancer, Flora McCoy-Greene sought the latest treatment from an integrated cancer care team at Mass General.
A study led by researchers at Mass General Brigham has found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.
Vaccines against SARS-CoV-2, the virus that causes COVID-19 infection, are safe in people undergoing treatment for cancer. The vaccines produced modestly impaired immune responses in patients with cancer, but booster vaccine doses enhanced immunity.
Radiation oncologists demonstrate in an early clinical trial that the radiation beam can be carefully “sculpted” to deliver the majority of a dose directly to the tumor while effectively sparing tissues in the side of the esophagus away from the affected lung.
Drugs that inhibit the protein expressed by a mutated form of the KRAS gene might soon be approved, but cancer cells often develop additional mutations that make them resist such targeted drugs. Investigators have identified some of these mutations in a patient and strategies to overcome them.
Lung cancer patients with a specific genetic alteration lived longer and were protected against metastasis to the brain when treated early with the drug lorlatinib.